BIH Digital Health Accelerator

What BIH Digital Health Accelerator does

The BIH Digital Health Accelerator (BIH DHA) is a non-profit, government-affiliated academic accelerator program established in 2017 and operated under the Digital Labs unit of Charité BIH Innovation, the joint technology transfer organization of Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH). It funds, mentors, and supports Charité/BIH clinicians and researchers to translate digital health concepts and clinical research results into market-ready medical solutions via licensing or spin-off formation. The program recruits project teams at all stages of readiness, with current capacity at 18 active projects (11 in Stage 1, 7 in Stage 2) and 9+ spin-offs graduated to date, including aignostics, mTOMADY, and TimeTeller.

The portfolio spans clinical decision support systems (RadiologyFlow, UroSavvy, ida), in-silico and in-vitro diagnostics (METIS, mucoaid, VarFish), digital therapeutics (safeBirth, VirtuCueR, myne, Open.IU), patient-facing solutions (DAGI, Midwife Roberta, Visions, ODEYA), and a broad set of AI/ML-powered tools built on computer vision, natural language processing, predictive analytics, anomaly detection, and sensor/wearable data. Underlying technologies include AI/machine learning, robotics, sensors, and XR, with key technology partners such as neomento (VR psychiatry) and SectorCon (sensor-based monitoring).

The business model is institutional rather than commercial: the program is funded through Charité and BIH as a translational research initiative, provides support at no cost to selected project teams, and does not generate commercial revenue or charge pricing. Its distribution is event-driven through annual open application calls (currently the 2026 Call), cohort-based mentorship, and Demo Days that connect portfolio companies with investors, hospital partners (including German Heart Center Berlin), and industry collaborators (Max Delbrück Center, DZNE, ZKRD, neomento, SectorCon). The primary customer segment is Charité/BIH clinicians and researchers, with secondary stakeholder segments including serial entrepreneurs, mentors, investors, industry partners, and hospital partners.

Name

BIH Digital Health Accelerator

Legal name

Berlin Institute of Health at Charité (BIH) - Translational Research Unit of Charité – Universitätsmedizin Berlin

Website

https://dha.bihealth.org

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

The BIH Digital Health Accelerator is a non-profit academic program, founded in 2017 and operated by Charité BIH Innovation, that funds and mentors Charité/BIH clinicians and researchers to translate digital health innovations into market-ready solutions and spin-offs. It currently supports 18 projects and has produced 9+ spin-offs across AI/ML, sensors, and digital therapeutics.

Ownership category

akta.pro rank

Product category

Digital Health Accelerator Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)

akta.pro primary industry

Data Platform, BI & Analytics Integration (BPAEAAAI)

Keywords

• Digital health accelerator
• Translational research support
• Spin-off incubation
• Healthcare venture building
• Clinical innovation funding

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Accelerator Program Funding: BIH Digital Health Accelerator is a funded program that provides financial support, mentorship, and guidance to Charité/BIH clinicians and researchers to develop digital health solutions. The program does not generate commercial revenue; it is a translational research initiative of the Berlin Institute of Health at Charité.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

The BIH Digital Health Accelerator is a non-profit, cohort-based program of the Berlin Institute of Health at Charité that funds, guides, and supports Charité and BIH clinicians and researchers to translate digital health concepts into market-ready medical solutions. Projects are incubated through staged funding, international mentorship, and clinical access within Charité's hospital, with outputs released either via licensing or spin-off companies. The program covers AI/ML diagnostics, clinical decision support, digital therapeutics, sensors, robotics, and XR-based medical tools.

Product overview

The BIH Digital Health Accelerator is a program that funds, guides, and supports Charité/BIH clinicians and researchers to turn digital health concepts into market-ready medical solutions. The portfolio includes diverse digital health products spanning clinical decision support systems (RadiologyFlow, UroSavvy, ida), in-vilvo diagnostics (METIS, mucoaid), digital therapeutics (safeBirth, VirtuCueR, myne, Open.IU), patient-facing solutions (DAGI, Midwife Roberta, Visions, ODEYA), and AI/ML-powered tools (ARCAS, VarFish, Deep Brain Decode, FRACTALYZER). Technologies employed include AI/machine learning, computer vision, robotics, sensors, and XR. The program supports projects at various stages from concept through pre-market commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

• BIH Digital Health Accelerator Program A non-profit accelerator program operated by the Berlin Institute of Health at Charité (BIH) that funds, guides, and supports Charité/BIH clinicians and researchers to translate digital health concepts into market-ready medical solutions via licensing or spin-off. The program provides staged funding, mentorship, and access to clinical environments across AI/ML, digital therapeutics, clinical decision support, sensors, and XR-based projects.
• aignostics AI-based precision diagnostics spin-off serving pharmaceutical research, clinical trials, and digital pathology.
• mTOMADY Mobile transaction spin-off enabling accessible and affordable healthcare payments in low- and middle-income countries.
• TimeTeller Circadian clock profiling spin-off that informs optimal cancer treatment timing.
• dotPD Customizable spin-off platform for data-driven medicine and healthcare IT / HIS integration.
• RadioEye AI-based radiology image-search spin-off platform providing diagnosis support via interactive case collection and a curated radiological image database.

Quantifiable outcome

• 9+ spin-offs successfully graduated from the program
• +2 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability43 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core.

• ZKRD (Central German Matching Service)coreStrategic or Co-development PartnerMatchGraft.AI project is working with ZKRD for stem cell donor-patient matching optimization. ZKRD provides access to national transplant data and expertise for algorithm validation.
• Charité HLA LabcoreStrategic or Co-development PartnerMatchGraft.AI collaborates with Charité's HLA laboratory in Berlin for stem cell transplantation matching data and validation.
• Fred Hutchinson Cancer Research CentercoreStrategic or Co-development PartnerMatchGraft.AI will receive additional data from this top US transplant center to support multiethnic dataset development for improved donor matching algorithms.
• neomento GmbHcoreTechnology or IntegrationVirtuCueR's technology partner specializing in development of VR-based medical products for psychiatry, providing technical expertise for virtual reality therapy platform.
• SectorConcoreTechnology or IntegrationAurelia's technology partner for developing the sensor-based non-invasive brain perfusion monitoring system for anesthesia.
• Max Delbrück Center for Molecular Medicine (MDC)coreStrategic or Co-development PartnerCollaboration with MDC for projects like Arcas (AI for life sciences) and Malva, bringing additional research expertise to the accelerator ecosystem.
• DZNE (German Center for Neurodegenerative Diseases)coreStrategic or Co-development PartnerResearch partner for CalciQuant project focused on CNS drug development analysis, bringing expertise in neuroscience research.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Bayer CoLaborator: Corporate-sponsored life-sciences incubator targeting early-stage biotech/health-tech ventures with pharma partnerships — comparable as a venture development program serving hospital and academic spin-outs, though anchored to a strategic investor rather than a hospital.
• EIT Health: European public-private health innovation network running accelerator and scale-up programs across the EU; overlaps with BIH DHA in digital-health venture support across Germany/Europe but at pan-European rather than single-hospital scope.

Regional players

• BioM Biotech Cluster Development GmbH: Munich-based German biotech/life-sciences cluster management with accelerator-style offerings — comparable as a regional European biomedical innovation intermediary, though not strictly a hospital-embedded accelerator.
• Health Innovation Hub (hih) Germany: German federal-government-backed healthcare innovation hub supporting digital health ventures via pilots with the healthcare system — comparable to BIH DHA as a domestic German digital-health accelerator with public-sector backing.

Direct peers

• Startupbootcamp Digital Health: Venture-backed digital health accelerator with cohort cycles, mentor networks and Demo Days targeting early-stage digital health startups — directly comparable GTM model and program design to BIH DHA.
• Cleveland Clinic Innovations: Commercialization vehicle of Cleveland Clinic that funds, accelerates and spins out clinician-led digital health and medical-device ventures — a benchmark hospital-accelerator comparable in mission, ecosystem and central role of clinical validation.
• Cedars-Sinai Accelerator: Hospital-embedded digital health/health-tech accelerator powered by Cedars-Sinai Medical Center — directly comparable structure to BIH DHA in combining clinical-data access, mentorship, and seed-stage company formation at a major academic medical center.
• Mass General Brigham Innovation (MGB Innovation): Technology-transfer and commercialization arm of Mass General Brigham, runs hospital-affiliated digital health and med-tech programs akin to BIH DHA's Charité BIH Innovation parent, sharing similar sourcing-from-clinicians models.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/berlinnovation
• LinkedInlinkedin.com/company/bih-digital-health-accelerator
• Instagraminstagram.com/berlininstituteofhealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIH Digital Health Accelerator